x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2004 > Familial Cancer
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Description

Cancer can be defined as the consequence of the accumulation of mutations in two kinds of genes: proto-oncogenes and tumour suppressor genes. The key mechanism behind hereditary or familial cancer are mutations in these genes in a germinal cell that are therefore transmitted to the progeny.
When an individual inherits a mutation it will occur in all cells, and there will be a high probability that neoplasia will develop as a consequence. Between 5-10% of all tumours are of a hereditary type. Genes involved in this class of cancer have both a varying degree of penetrance and transmission. Clinical prevention and treatment, and study of such cancers demands individual risk analysis for each member belonging to the family in question - namely, genetic counselling.
This conference will deal with all these subjects related to familial cancer.

General information

Conference venue
Centro Nacional de Investigaciones Oncológicas
Melchor Fernández Almagro No 3
28029 Madrid, Spain
Tel: +34 91 224 6900
Fax: +34 91 224 6980
e-mail: meetings@cnio.es

Organising secretariat
Daniela Mengato
European School of Oncology
Viale Beatrice d'Este, 37
20122 Milan, Italy
Tel: +39 02 4335 9611
Fax: +39 02 4335 9640
e-mail: conferences@esoncology.org

Confirmation of registration
Registration will only be confirmed upon receipt of the registration fee. A combined confirmation of registration / acknowledgement of payment will be sent to you by mail, fax or e-mail.

Cancellation of registration
In case of cancellation without replacement, the fee less handling charges of € 56 will be refunded, provided a written request is received by the European School of Oncology before 6 April 2004. No refund can be made if notice of cancellation is received after this date. Any refund will be made after the conference.

CME accreditation
The European School of Oncology will apply for CME credits to the Accreditation Council of Oncolgy in Europe and to the Italian Ministry of Health.
Each participant will receive a certificate of attendance stating the relevant number of credits obtained during the conference.
American doctors attending the conference can report this to the AMA and receive AMA PRA Cat. 1 credit.
The CME certificates can be granted only to the participants who have attended the entire conference. The CME certificates will be distributed at the end of the meeting. 

Abstract